Leading cardiovascular research in the UK since 1961
We’re the biggest non-commercial funder of cardiovascular research in the UK, funding research that has improved the lives of millions of people.
Funding for success
We’re proud of BHF’s track record of funding research, which has had real impact on cardiovascular health. But there's still much more to do. We’re determined to continue to invest in the talented researchers, novel ideas and technology needed to make the next lifesaving discoveries.
Innovation in heart and circulatory science
Our biggest ever research grant – our Big Beat Challenge
The Big Beat Challenge was awarded to CureHeart, a project seeking new cures and treatments for inherited heart muscle diseases.
Using the power of big data to tackle heart and circulatory disease
We’ve been supporting big data studies, which are vital in understanding what causes diseases and how to prevent and treat them.
Putting people first
Involving patients in our research
People with lived experience of cardiovascular disease share their insight with us so we can help save and improve more lives.
Supporting the research stars of the future
Since we began 60 years ago, we’ve been training generations of researchers and supporting world-leading scientists to improve people’s lives.
Bringing lab discoveries to patients more quickly
Translating findings from the lab into advances in human health can take decades. We’re working to bring science discoveries to patients more quickly.
Covid-19 and cardiovascular health
Supporting the fight against Covid-19
During the pandemic, many of our researchers redirected their expertise to help us understand the effects of Covid-19.
Working with the NIHR on Covid-19 research
The NIHR-BHF Cardiovascular Partnership created a framework to set-up and deliver impactful Covid-19 research projects across the UK.
Informing and supporting the public about Covid-19
During the pandemic, we provided coronavirus updates from our experts, including what Covid-19 means if you have a heart or circulatory condition.
New horizons in big data
Big data and artificial intelligence are helping us to better calculate risk from surgery and from Covid-19.